Mast cell in infantile hemangioma

Mast cell in infantile hemangioma

Infantile hemangioma (IH) is the most common benign vascular tumor characterized by three phases — proliferation, early involution and late involution. Mast cells (MCs) play an important role in allergic reactions and numerous diseases, including tumors. While the mechanisms underlying MCs migration...

Full description

Bibliographic Details
Main Authors:	Meng Xia, Wenying Liu, Fang Hou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Oncology
Subjects:	infantile hemangioma mast cell estradiol proangiogenesis anti-angiogenesis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1304478/full

Similar Items

Estrogen is involved in hemangioma regression associated with mast cells
by: Fang Hou, et al.
Published: (2018-10-01)

Differentiation and Pro-Angiogenic Potential of Infantile Hemangioma Stem Cells
by: Hanru YING, et al.
Published: (2020-03-01)

Identification of novel potential biomarkers in infantile hemangioma via weighted gene co-expression network analysis
by: Bin Xie, et al.
Published: (2022-05-01)

Circulating Mesenchymal Stromal Cells in Patients with Infantile Hemangioma: Evaluation of Their Functional Capacity and Gene Expression Profile
by: Carlotta Abbà, et al.
Published: (2024-01-01)

Identification of Key microRNAs and Genes in Infantile Hemangiomas
by: Cong Fu, et al.
Published: (2022-03-01)

Hemangiomas versus arterio-venous malformations: Role of elastic stains and mast cell density
by: Pravin Pawane, et al.
Published: (2014-01-01)

Role of connexins in infantile hemangiomas
by: Katja eBlanke, et al.
Published: (2013-04-01)

Approach to infantile hemangiomas
by: Anil Abraham, et al.
Published: (2016-01-01)

Editorial: Advances in the medical management of infantile hemangioma
by: Haiwei Wu, et al.
Published: (2023-06-01)

Hemangiomas infantiles
by: Carolina Hernández-Zepeda, et al.
Published: (2017-05-01)

Current perspectives on the optimal management of infantile hemangioma
by: Grzesik P, et al.
Published: (2017-12-01)

Propranolol in the Treatment of Infantile Hemangiomas
by: Tan X, et al.
Published: (2021-09-01)

Infantile Hemangiomas: An Update on Pathogenesis and Treatment
by: Małgorzata Kowalska, et al.
Published: (2021-10-01)

The prevalence and risk factors for visceral hemangiomas in children with infantile cutaneous hemangiomas
by: Mirela-Elena Ritivoiu, et al.
Published: (2022-09-01)

Post-Burn Infantile Hemangioma in an Extremely Premature Neonate
by: Flavia Rosa-Mangeret, et al.
Published: (2020-08-01)

Infantile hemangioma
by: Marta Kurzeja, et al.
Published: (2022-10-01)

Thermography as a Method for Bedside Monitoring of Infantile Hemangiomas
by: Juan Antonio Leñero-Bardallo, et al.
Published: (2022-11-01)

Infantile hepatic hemangioma complicated consumptive hypothyroidism
by: Qianlong Liu, et al.
Published: (2021-10-01)

Infantile Hemangioma Treated with Oral Propranolol: Case Presentation
by: Raufi N, et al.
Published: (2021-08-01)

Variable response to propranolol therapy for infantile hemangiomas
by: Vishesh Jain, et al.
Published: (2012-01-01)

Infantile hemangiomas: An update on pathogenesis, associations, and management
by: Karina L Vivar, et al.
Published: (2018-01-01)

Excellent Response of Infantile Hemangioma with Oral Propranolol: A Case Report
by: Armyta Denissafitri, et al.
Published: (2022-11-01)

Progressing eczematous dermatitis in an infantile hemangioma with minimal or arrested growth treated with tacrolimus ointment
by: Raya Qais Alsaid, MD, et al.
Published: (2020-06-01)

Treatment outcomes of oral propranolol in the treatment of periocular infantile capillary hemangioma and factors predictive of recurrence and incomplete resolution: A multi-centric study
by: Sweety Tiple, et al.
Published: (2023-01-01)

Mast cells in meningiomas
by: Antonio D'Amati, et al.
Published: (2024-04-01)

Intralesional injection of bevacizumab versus triamcinolone acetonide in infantile hemangioma
by: Hanan H. Sabry, et al.
Published: (2020-04-01)

Deep coma in a child treated with propranolol for infantile hemangioma
by: Ilirjana Bakalli, et al.
Published: (2019-07-01)

Diagnóstico y manejo de hemangiomas infantiles.
by: Catalina Castrillo Hine, et al.
Published: (2022-04-01)

15, 16-Dihydrotanshinone I Inhibits Hemangiomas through Inducing Pro-apoptotic and Anti-angiogenic Mechanisms in Vitro and in Vivo
by: Yihong Cai, et al.
Published: (2018-01-01)

Gastrointestinal infantile hemangioma: A rare cause of digestive tract bleeding in children to consider
by: Idalia Cura‐Esquivel, et al.
Published: (2021-09-01)

Embolization of congenital hemangioma with severe hemorrhage
by: Masafumi Kamata, et al.
Published: (2021-02-01)

Diffuse infantile hepatic hemangioma successfully treated with propranolol orally: a case report and literature review
by: Zengyan Li, et al.
Published: (2024-01-01)

Management of infantile hemangiomas: Recent advances
by: Wei Xu, et al.
Published: (2022-11-01)

Infantile Hemangioma: A Retrospective Study
by: Eva Lydiawati, et al.
Published: (2020-03-01)

Oral atenolol compared to oral propranolol for infantile hemangioma
by: Victor Meza Viteri, et al.
Published: (2023-12-01)

The Profiles of Infantile Hemangiomas Patients
by: Arie hidayati, et al.
Published: (2023-07-01)

Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma
by: Kaiying Yang, et al.
Published: (2023-02-01)

Isolation, characterization, and <it>in vitro </it>propagation of infantile hemangioma stem cells and an <it>in vivo </it>mouse model
by: Xu Dan, et al.
Published: (2011-12-01)

Importance of Determining Vascular Endothelial Growth Factor Serum Levels in Children with Infantile Hemangioma
by: Arnes Rešić, et al.
Published: (2023-10-01)

Infantile hemangioma models: is the needle in a haystack?
by: Meng Kong, et al.
Published: (2023-05-01)